|
Romidepsin Clinical Trials
2 actively recruiting trials across 2 locations
Also known as: Depsipeptide
Tampa, Florida1 trial
Study Investigating Intravesical HDAC Inhibition to Improve Response to Immuno-Oncology Agents
Moffitt Cancer Center
Phase 1
Charlottesville, Virginia1 trial
Durvalumab in Different Combinations With Pralatrexate, Romidepsin and Oral 5-Azacitidine for Lymphoma
University of Virginia
Phase 1/2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.